Defining Bacillus Calmette-Guerin Refractory Superficial Bladder Tumors
Authors:
- 1 May 2003
- journal article
- Published by Wolters Kluwer Health in Journal of Urology
- Vol. 169 (5) , 1706-1708
Abstract
Purpose: We define bacillus Calmette-Guerin (BCG) refractory, high risk, superficial bladder cancer.Materials and Methods: A total of 93 patients received a 6-week induction course of BCG. ...Keywords
This publication has 16 references indexed in Scilit:
- Phase I Trial of Intravesical Gemcitabine in Bacillus Calmette-Guérin–Refractory Transitional-Cell Carcinoma of the BladderJournal of Clinical Oncology, 2002
- DOES EARLY CYSTECTOMY IMPROVE THE SURVIVAL OF PATIENTS WITH HIGH RISK SUPERFICIAL BLADDER TUMORS?Journal of Urology, 2001
- CLINICAL EXPERIENCE WITH 5-AMINOLEVULINIC ACID AND PHOTODYNAMIC THERAPY FOR REFRACTORY SUPERFICIAL BLADDER CANCERJournal of Urology, 2001
- THE LIMITS OF BACILLUS CALMETTE-GUERIN FOR CARCINOMA IN SITU OF THE BLADDERJournal of Urology, 2001
- EFFICACY AND SAFETY OF VALRUBICIN FOR THE TREATMENT OF BACILLUS CALMETTE-GUERIN REFRACTORY CARCINOMA IN SITU OF THE BLADDERJournal of Urology, 2000
- PHOTODYNAMIC THERAPY USING PORFIMER SODIUM AS AN ALTERNATIVE TO CYSTECTOMY IN PATIENTS WITH REFRACTORY TRANSITIONAL CELL CARCINOMA IN SITU OF THE BLADDERJournal of Urology, 1998
- Oral bropirimine immunotherapy of bladder carcinoma in situ after prior intravesical bacille Calmette-GuérinUrology, 1998
- Initial report on intraves1cal administration of N-trifluoroacetyladriamycin-14-valerate (AD 32) to patients with refractory superficial transitional cell carcinoma of the urinary bladderUrology, 1997
- Oral bropirimine immunotherapy of carcinoma in situ of the bladder: results of a phase II trialUrology, 1996
- Analysis of early failures after intravesical instillation therapy with bacille Calmette‐Guerin for carcinoma in situ of the bladderBritish Journal of Urology, 1995